Categories Consumer, Earnings

Earnings: Kimberly-Clark posts upbeat Q1 sales and profit

Personal-care retailing giant Kimberly-Clark (KMB) posted its first-quarter 2019 earnings on Monday before the opening bell.

Net sales slipped 2% to $4.6 billion, while attributable earning grew almost five-fold to $454 million or $1.31 per diluted share (from Q1 2018 earnings of $93 million or $0.26 per share). First-quarter adjusted earnings fell to $1.66 per share from the year-ago earnings of $1.71 per share.

Kimberly-Clark (KMB) Q1 2019 Earnings Infographic

Analysts expected Kimberly-Clark’s adjusted earnings at about $1.55 per share on revenue of about $4.53 billion for the first quarter. Both metrics were beaten by the results.

Major consumer packaged goods manufacturers including Colgate-Palmolive (CL) and Procter & Gamble (PG) have remained on the sidelines as this quarter’s results could be hurt by currency volatility and continued inflation in commodities. Colgate is expected to post lower top and bottom lines for the first quarter, while Procter & Gamble’s third-quarter results are likely to stay low.

Also read: Elon Musk goes to war with Panasonic on Twitter

Kimberly-Clark CEO Mike Hsu, as the company announced quarterly results, commented, “…we generated $115 million of cost savings and returned $510 million to shareholders through dividends and share repurchases. We are confirming our previous full-year outlook while we maintain a strong focus on executing K-C Strategy 2022 for long-term success.”

Image Courtesy: Kimberly-Clark / Facebook page 


Back in the first month of 2018, Kimberly-Clark flagged off a “2018 Global Restructuring Program” to cut its structural cost base and lift the company’s flexibility to invest in its brands, growth initiatives and capabilities critical to delivering future growth.

Now, Kimberly-Clark said it expects the program to generate annual pre-tax cost savings of $500-550 million by the end of 2021. “As part of the program, Kimberly-Clark expects to exit or divest some low-margin businesses that generate approximately 1 percent of company net sales. The sales are concentrated in the consumer tissue business segment. To implement the program, the company expects to incur restructuring charges of $1,700 to $1,900 million pre-tax ($1,350 to $1,500 million after tax) by the end of 2020,” a statement by the company read.

As of the currently reported first-quarter, restructuring charges were $152 million pre-tax and $122 million post-tax. In the quarter, the company said it recorded restructuring savings of $60 million.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Should investors worry about Micron’s (MU) weak Q4 results and guidance?

The semiconductor industry is a rapidly growing business segment that currently thrives on the digital transformation wave. The demand for memory chips and other semiconductor products increased over the years,

What has Bed Bath & Beyond (BBBY) outlined for this fiscal year?

Shares of Bed Bath & Beyond (NASDAQ: BBBY) were up on Friday, a day after the company delivered disappointing results for the second quarter of 2022. The company reported a

NKE Earnings: Highlights of Nike’s Q1 2023 results

Nike, Inc. (NYSE: NKE) has reported a decrease in net profit for the first quarter of 2023, despite a modest increase in revenues. The company's stock suffered a big loss

Add Comment
Viewing Highlight